1-4 of 4
Nathan R. Hill
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Expansion of the Homeostasis Model Assessment of β-Cell Function and Insulin Resistance to Enable Clinical Trial Outcome Modeling Through the Interactive Adjustment of Physiology and Treatment Effects: iHOMA2. Diabetes Care 2013;36: 2324–2330

Open Access
Nathan R. Hill, Jonathan C. Levy, David R. Matthews
Journal: Diabetes Care
Diabetes Care 2014;37(9):2660
https://doi.org/10.2337/dc14-er09a
Published: 07 August 2014
View articletitled, Expansion of the Homeostasis Model Assessment of β-Cell Function and Insulin Resistance to Enable Clinical Trial Outcome Modeling Through the Interactive Adjustment of Physiology and Treatment Effects: iHOMA2. Diabetes Care 2013;36: 2324–2330
Open the PDF for Expansion of the Homeostasis Model Assessment of β-Cell Function and Insulin Resistance to Enable Clinical Trial Outcome Modeling Through the Interactive Adjustment of Physiology and Treatment Effects: iHOMA2. Diabetes Care 2013;36: 2324–2330 in another window
Journal Articles

Cyclical Variation in HbA1c Values During the Year: Clinical and Research Implications

Open Access
Nathan R. Hill, PHD, Catherine J. Peters, MD, Rebecca J. Thompson, MSC, David R. Matthews, DPhil, Peter C. Hindmarsh, MD
Journal: Diabetes Care
Diabetes Care 2013;36(10):e175–e176
https://doi.org/10.2337/dc13-1247
Published: 14 September 2013
View articletitled, Cyclical Variation in HbA1c Values During the Year: Clinical and Research Implications
Open the PDF for Cyclical Variation in HbA1c Values During the Year: Clinical and Research Implications in another window
Journal Articles

Expansion of the Homeostasis Model Assessment of β-Cell Function and Insulin Resistance to Enable Clinical Trial Outcome Modeling Through the Interactive Adjustment of Physiology and Treatment Effects: iHOMA2

Open Access
Nathan R. Hill, DPHIL (OXON), Jonathan C. Levy, FRCP, David R. Matthews, DPHIL (OXON)
Journal: Diabetes Care
Diabetes Care 2013;36(8):2324–2330
https://doi.org/10.2337/dc12-0607
Published: 11 July 2013
View articletitled, Expansion of the Homeostasis Model Assessment of β-Cell Function and Insulin Resistance to Enable Clinical Trial Outcome Modeling Through the Interactive Adjustment of Physiology and Treatment Effects: iHOMA2
Open the PDF for Expansion of the Homeostasis Model Assessment of β-Cell Function and Insulin Resistance to Enable Clinical Trial Outcome Modeling Through the Interactive Adjustment of Physiology and Treatment Effects: iHOMA2 in another window
Journal Articles

Validation of Continuous Glucose Monitoring in Children and Adolescents With Cystic Fibrosis: A prospective cohort study

Open Access
Stephen M.P. O'Riordan, MRCPI, MD, Peter Hindmarsh, MD, FRCPCH, Nathan R. Hill, DPHIL, MBCS, David R. Matthews, DPHIL, FRCP, Sherly George, MSC, Peter Greally, MD, FRCPI, Gerard Canny, MD, FRCPI, Dubhfeasa Slattery, PHD, FRCPI, Nuala Murphy, MD, FRCPI, Edna Roche, MD, FRCPI, Colm Costigan, FRCPI, Hilary Hoey, MD, FRCPI
Journal: Diabetes Care
Diabetes Care 2009;32(6):1020–1022
https://doi.org/10.2337/dc08-1925
Published: 11 March 2009
View articletitled, Validation of Continuous Glucose Monitoring in Children and Adolescents With Cystic Fibrosis: A prospective cohort study
Open the PDF for Validation of Continuous Glucose Monitoring in Children and Adolescents With Cystic Fibrosis: A prospective cohort study in another window